A comparison of bilateral with single internal mammary artery grafts on postoperative mediastinal drainage and transfusion requirement

Anesthesia and Analgesia

Volumn 103, Issue 6, 2006, Pages 1380-1385

  Berroeta, Clarisse ^a,d   Benbara, Abdel ^a   Provenchère, Sophie ^a   Ajzenberg, Nadine ^b   Benessiano, Joelle ^c   Depoix, Jean Pol ^a   Desmonts, Jean Marie ^a   Iung, Bernard ^d   Philip, Ivan ^a  

^a Département Anesthésie Réanimation   (France)

^b Laboratoire d'Hematologie   (France)

^c Centre d'Investigation Clinique   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE; CEFAMANDOLE; ETOMIDATE; FENTANYL; GENTAMICIN; HEPARIN; ISOFLURANE; LOW MOLECULAR WEIGHT HEPARIN; PANCURONIUM BROMIDE; PROPOFOL; TRANEXAMIC ACID; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; COMPARATIVE STUDY; CORONARY ARTERY BYPASS SURGERY; ELECTIVE SURGERY; FEMALE; GRAFT PATENCY; HEART MUSCLE REVASCULARIZATION; HEMATOCRIT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MULTIVARIATE ANALYSIS; OPERATION DURATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; SAPHENOUS VEIN GRAFT; SURGICAL DRAINAGE; SURGICAL RISK; SURVIVAL RATE; VEIN GRAFT;

ADULT; AGED; BLOOD TRANSFUSION; DRAINAGE; FEMALE; HUMANS; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; MALE; MEDIASTINUM; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; RISK FACTORS;

EID: 33845610580     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000242514.49621.0c     Document Type: Article

References (27)

1. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6.
2. Leavitt BJ, O'Connor GT, Olmstead EM, et al. Use of the internal mammary artery graft and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation 2001;103:507-12.
3. Edwards FH, Clark RE, Schwartz M. Impact of internal mammary artery conduits on operative mortality in coronary revascularization. Ann Thorac Surg 1994;57:27-32.
4. Rizzoli G, Schiavon L, Bellini P. Does the use of bilateral internal mammary artery (IMA) grafts provide incremental benefit relative to the use of a single IMA graft? A meta-analysis approach. Eur J Cardiothorac Surg 2002;22:781-6.
5. Pick AW, Orszulak TA, Anderson BJ, Schaff HV. Single versus bilateral internal mammary artery grafts: 10-year outcome analysis. Ann Thorac Surg 1997;64:599-605.
6. Lytle BW, Blackstone EH, Loop FD, et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 1999;117:855-72.
7. Cosgrove DM, Lytle BW, Loop FD, et al. Does bilateral internal mammary artery grafting increase surgical risk? J Thorac Cardiovasc Surg 1988;95:850-6.
8. Myers WO, Berg R, Ray JF, et al. All-artery multigraft coronary artery bypass grafting with only internal thoracic arteries possible and safe: a randomized trial. Surgery 2000;128:650-9.
9. Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 2001;358:870-5.
10. Calafiore AM, Di Giammarco G, Teodori G, et al. Late results of first myocardial revascularization in multiple vessel disease: single versus bilateral internal mammary artery with or without saphenous vein grafts. Eur J Cardiothorac Surg 2004;26:542-8.
11. Grossi EA, Esposito R, Harris LJ, et al. Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 1991;102:342-6; discussion 6-7.
12. Uva MS, Braunberger E, Fisher M, et al. Does bilateral internal thoracic artery grafting increase surgical risk in diabetic patients? Ann Thorac Surg 1998;66:2051-5.
13. Gansera B, Gunzinger R, Angelis I, et al. End of the millennium - end of the single thoracic artery graft? Two thoracic arteries - standard for the next millenium? Early clinical results and analysis of risk factors in 1,487 patients with bilateral internal thoracic artery grafts. Thorac Cardiovasc Surg 2001;49:10-15.
14. Walkes JC, Earle N, Reardon MJ, et al. Outcomes in single versus bilateral internal thoracic artery grafting in coronary artery bypass surgery. Curr Opin Cardiol 2002;17:598-601.
15. Endo M, Nishida H, Tomizawa Y, Kasanuki H. Benefit of bilateral over single internal mammary artery grafts for multiple coronary artery bypass grafting. Circulation 2001;104:2164-70.
16. Cassese M, Speziali G, Martinelli GL, Diena M. Reduced complication rate in bilateral mammary artery-to-coronary artery bypass grafting. Ann Thorac Surg 1998;65:1841-2.
17. Provenchere S, Plantefeve G, Hufnagel G, et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors, and effect on clinical outcome. Anesth Analg 2003;96:1258-64.
18. Endo M, Tomizawa Y, Nishida H. Bilateral versus unilateral internal mammary revascularization in patients with diabetes. Circulation 2003;108:1343-9.
19. Cohn L. Use of the internal mammary artery graft and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation 2001;103:483-4.
20. Stevens LM, Carrier M, Perrault LP, et al. Single versus bilateral internal thoracic artery grafts with concomitant saphenous vein grafts for multivessel coronary artery bypass grafting: effects on mortality and event-free survival. J Thorac Cardiovasc Surg 2004;127:1408-15.
21. Fiore AC, Naunheim KS, Dean P, et al. Results of internal thoracic artery grafting over 15 years: single versus double grafts. Ann Thorac Surg 1990;49:202-8; discussion 8-9.
22. Barner HB, Standeven JW, Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac Cardiovasc Surg 1985;90:668-75.
23. Moskowitz DM, Klein JJ, Shander A, et al. Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Ann Thorac Surg 2004;77:626-34.
24. Dial S, Delabays E, Albert M, et al. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. J Thorac Cardiovasc Surg 2005;130:654.
25. Taggart DP, Djapardy V, Naik M, Davies A. A randomized trial of aprotinin (Trasylol) on blood loss, blood product requirement, and myocardial injury in total arterial grafting. J Thorac Cardiovasc Surg 2003;126:1087-94.
26. Bybee KA, Powell BD, Valeti U, et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005;112:I286-92.
27. van der Linden J, Lindvall G, Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation 2005;112:I276-80.